Secondary peritonitis includes community-acquired and nosocomial peritonitis. These intra-abdominal infections have a common pathogenesis but some microbiological differences, particularly with respect to the type of bacteria recovered and the level of antimicrobial susceptibility. This report describes a prospective observational study of 93 consecutive patients with secondary peritonitis during an 11month period. Community-acquired peritonitis accounted for 44 cases and nosocomial peritonitis for 49 cases (post-operative in 35 cases). Fifteen multidrug-resistant (MDR) bacteria were recovered from 14 patients. In univariate analysis, the presence of MDR bacteria was associated significantly with preoperative and total hospital lengths of stay, previous use of antimicrobial therapy, and post-operative antimicrobial therapy duration and modifications. A 5-day cut-off in length of hospital stay had the best specificity (58%) and sensitivity (93%) for predicting whether MDR bacteria were present. In multivariate analysis, only a composite variable associating pre-operative hospital length of stay and previous use of antimicrobial therapy was a significant independent risk-factor for infection with MDR bacteria. In conclusion, knowledge of these two factors may provide a more rational basis for selecting initial antimicrobial therapy for patients with secondary peritonitis.
I N T R O D U C T I O N
Secondary peritonitis is a common disease that includes a broad variety of pathological conditions, including community-acquired peritonitis and nosocomial peritonitis (including post-operative peritonitis) [1] . A perforation of the gastrointestinal tract, with or without a previous surgical intervention, is characteristic of all of these intraabdominal infections. However, these infections have some microbiological differences in terms of the spectrum of bacteria involved and their level of antibiotic susceptibility [2] [3] [4] [5] [6] . For example, Escherichia coli is recovered less frequently from cases of post-operative peritonitis than from cases of community-acquired peritonitis, whereas Enterococcus spp. and Enterobacter spp. are recovered more frequently from cases of post-operative peritonitis. Moreover, multidrug-resistant (MDR) bacteria are recovered more frequently from cases of post-operative peritonitis. In this context, resistant and MDR bacteria were shown to be present in 70% and 37% of cases, respectively [2] . Preceding antibiotic use may also play a role by modifying the spectrum of the bacterial flora and the level of antibiotic susceptibility [3] .
These data have resulted in the proposal of antimicrobial regimens with an extended spectrum for cases of post-operative peritonitis, and also for patients with a prolonged pre-operative hospital stay and prolonged (>2 days) pre-operative antimicrobial therapy [7] . Nevertheless, such an approach could lead to excessive prescribing of expensive broad-spectrum antibiotics. Indeed, it has been demonstrated that the microbiological findings for nosocomial non-post-operative peritonitis are quite similar to those for communityacquired peritonitis, although a low proportion of nosocomial flora was nevertheless present [6] . In this context, the present report describes a prospective study to determine the risk-factors for infection by MDR bacteria in secondary peritonitis in order to determine a more suitable initial therapeutic approach.
M A T E R I A L S A N D M E T H O D S
This prospective observational study was conducted between 1 November 2003 and 1 October 2004 in a 1980-bed teaching hospital that serves as both a referral centre and a primary-care centre. The hospital has one department of gastrointestinal surgery, dealing mainly with patients with hepatobiliary defects and malignancies, and one surgical intensive care unit, which operates as a closed unit. The study was submitted to the local ethical committee, which decided that informed consent was not necessary.
All adult (aged ‡15 years) patients admitted for secondary peritonitis, defined as diffuse peritonitis originating from a defect in the abdominal viscus [1] , were included in the study. Patients who did not undergo bacteriological investigation, and those with pancreatitis or gynaecological infections, were excluded. The origin of the peritonitis was determined (stomach ⁄ duodenum, small bowel, colon, appendix or biliary). In cases of post-operative peritonitis attributed to anastomosis leakage, the origin was defined by the most contaminated site. Peritonitis was classified as community-acquired or nosocomial, and in the latter case, as post-operative or non-post-operative.
The following data were recorded within 24 h of the diagnosis of secondary peritonitis: age; gender; severity of the underlying disease, defined according to the criteria of McCabe and Jackson [8] as not fatal (class 1), ultimately fatal (class 2), and fatal (class 3); Simplified Acute Physiologic Score II (SAPS II) [9] ; and Acute Physiology and Chronic Health Evaluation II (APACHE II) score [10] . The presence of septic shock and ⁄ or bloodstream infection, and ⁄ or acute respiratory distress syndrome, and ⁄ or acute renal failure, was also recorded. Pre-operative hospital stay and previous use of antimicrobial therapy before surgical treatment for peritonitis were noted. Duration and modifications of post-operative antimicrobial therapy, total length of hospital stay and mortality at day +30 were also recorded. During the post-operative period, any digestive complications or need for further surgery were recorded.
Two blood cultures (aerobic and anaerobic) were taken during the perioperative period. One or more peritoneal fluid sample(s) were also taken during surgery. These samples were inoculated on to an aerobic medium (trypticase soya agar) and an anaerobic medium (blood agar) and incubated at 37°C. Antibiotic susceptibilities of bacterial isolates were determined by the disk-diffusion method (Bio-Rad, Marnes la Coquettes, France), according to the recommendations of the Antibiogram Committee of the French Microbiology Society (CA-SFM; http://www.sfm.assoc.fr). The bacteria were then classified as susceptible or resistant (resistant and intermediately-resistant combined). The susceptibilities of aerobic Gram-negative bacteria were determined for 13 antibiotics (amoxycillin, amoxycillin-clavulanic acid, ticarcillin, ticarcillin-clavulanic acid, piperacillin, piperacillin-tazobactam, cefotaxime, ceftazidime, cefepime, imipenem, gentamicin, amikacin and ciprofloxacin). The susceptibilities of three aerobic Gram-positive bacteria (Enterococcus spp., Staphylococcus aureus, Streptococcus spp.) were determined for oxacillin (Staph. aureus, Streptococcus spp.), amoxycillin (Enterococcus spp.), vancomycin (Enterococcus spp., Staph. aureus, Streptococcus spp.), and gentamicin (Enterococcus spp., Streptococcus spp.). Enterobacteria with an intermediately-resistant or resistant result for a third-generation cephalosporin were screened systematically for the presence of extended-spectrum b-lactamases by the double-disk diffusion method, as described previously [11] . The susceptibilities of anaerobic bacteria were not studied.
Surgical chemoprophylaxis was prescribed according to the recommendations of the French Society of Anaesthesia and Intensive Care [12] and was managed by the anaesthesiologist. No antibiotic was added when intra-abdominal wash-out was performed by the surgeons. In this institution, the first-line antimicrobial therapy was a combination of cefotaxime and metronidazole for cases of community-acquired peritonitis, and a combination of ticarcillin-clavulanic acid and amikacin for cases of nosocomial peritonitis (both post-operative and non-post-operative).
Definitions
Nosocomial intra-abdominal infection was defined as an infection absent upon admission that became evident in patients 48 h or more after admission [13] . Prior antibiotic use was defined as the use of at least one antimicrobial agent for >2 days during the 15-day period preceding the intraabdominal infection. Bloodstream infection was defined as at least one positive blood culture (two positive cultures in the case of coagulase-negative staphylococci) reported as secondary to the intra-abdominal infection, unless another source of systemic infection, from which the bacteria was cultured, was known. Septic shock was defined according to the Bone criteria [14] , and acute respiratory distress syndrome was defined according to international consensus [15] . Acute renal failure was defined as a serum creatinine concentration >240 lmol ⁄ L and a serum urea concentration >16 mmol ⁄ L and ⁄ or a urine output <400 mL ⁄ 24 h and ⁄ or the need for dialysis. In the event of chronic renal failure, acute renal failure was defined as an increase in creatinine of >120 lmol ⁄ L or urea >8 mmol ⁄ L and ⁄ or a urine output <400 mL ⁄ 24 h and ⁄ or the need for dialysis [16] . MDR bacteria was defined as: methicillin-resistant Staph. aureus (MRSA); Enterococcus spp. resistant to vancomycin and to high levels of gentamicin; Enterobacteriaceae producing an extended-spectrum b-lactamase (e.g., Klebsiella spp., Enterobacter spp., Esch. coli and Proteus mirabilis) or producing a cephalosporinase (Enterobacter spp. and Serratia spp.); Pseudomonas aeruginosa resistant to ticarcillin, ceftazidime, imipenem or ciprofloxacin, or producing an extended-spectrum b-lactamase; and Acinetobacter spp. resistant to imipenem and ⁄ or ticarcillin and ⁄ or aminoglycosides.
Statistical analysis
Statistical analysis was performed using SAS Software v.8.02 (SAS Institute, Cary, NC, USA). Data are presented as means ± SD for continuous variables, and the number with the corresponding percentage for qualitative variables. The characteristics of patients infected with MDR bacteria, and those who were not, were compared using Student's t-test or Wilcoxon's rank sum test, as appropriate, for continuous variables, and the chi-square or Fisher's exact test, as appropriate, for categorical variables. To identify risk-factors associated independently with the occurrence of MDR bacteria, variables found to be significantly different between the two groups were entered into a forward stepwise logistic regression model. Each variable used in this logistic regression analysis concerned patients' characteristic before isolation of MDR and was binary; therefore, continuous variables were recoded by using receiver operating characteristic curves to define the cut-off point (represented by the value with the best sensitivity and specificity). Pairwise interactions were tested between the variables. In case of a significant interaction, a composite variable was created from the two corresponding variables. For all analyses, p <0.05 was considered to be significant.
R E S U L T S
Ninety-three patients were recruited during the study period. Community-acquired peritonitis accounted for 44 cases, and nosocomial peritonitis for 49 cases (post-operative in 35 cases). None of the cases of community-acquired peritonitis had a history of recent hospitalisation and ⁄ or antibiotic use. Community-acquired peritonitis was mainly appendicular (22 cases), followed by colic, upper bowel and biliar (12 cases, nine cases and one case, respectively). Nosocomial peritonitis involved primarily the colon (29 cases), followed by the upper bowel, biliary tract and appendix (15 cases, four cases and one case, respectively). Microorganisms recovered from intraperitoneal specimens are listed in Table 1 . The distribution of the microorganisms differed according to the aetiology of the peritonitis. Table 2 summarises the characteristics of patients with and without MDR bacteria. In univariate analysis, the risk for acquiring an MDR organism was associated significantly with a higher severity of underlying disease, as assessed by the McCabe index and the APA-CHE II score. In contrast, SAPS II was not associated with isolation of MDR bacteria, which occurred more frequently in cases of post-operative peritonitis. Pre-operative length of hospital stay and previous use of antimicrobial therapy, as well as the duration and modifications of postoperative antimicrobial therapy, were also associated significantly with the presence of MDR bacteria. Length of hospital stay was longer when an MDR bacterium was isolated, but mortality rates at day 30 did not differ between the two groups. Post-operative intra-abdominal complications were more frequent in patients with MDR a All cases were Candida albicans except for the cases of post-operative peritonitis, which comprised C. albicans (n = 3), Candida glabrata (n = 1) and Candida krusei (n = 1). bacteria (78% vs. 32%; p <0.001), and especially in those with infectious complications (57% vs. 19%; p 0.005). Further surgery was required by 14% of patients in both groups. Pre-operative length of hospital stay was transformed into a binary variable using a cut-off point of 5 days, as determined with the receiver operating characteristic curve, to give the best specificity (58%) and sensitivity (93%). A significant interaction was observed between pre-operative length of hospital stay and previous use of antimicrobial therapy. Consequently, a composite variable was created that included three modalities (pre-operative length of hospital stay <5 days, pre-operative length of hospital stay ‡5 days without previous use of antimicrobial therapy, and pre-operative length of hospital stay ‡5 days with previous use of antimicrobial therapy). In the first modality, previous use of antimicrobial therapy was not taken into account because only one patient developed an MDR bacterial infection. In multivariate analysis, only the composite variable was found to be a significant independent risk-factor for MDR bacterial infection, showing that patients with a preoperative length of hospital stay of ‡5 days had a higher risk for developing an MDR bacterial infection, especially when antibiotics had been used previously (Table 3) .
Fifteen MDR bacteria were isolated from 14 patients (Enterobacter aerogenes and P. aeruginosa from one patient). The bacteria isolated were Enterobacter spp. (n = 8; two Ent. aerogenes, six Enterobacter cloacae); MRSA (n = 3); P. aeruginosa (n = 2); Enterococcus spp. (n = 1); and Esch. coli (n = 1) ( Table 3 ).
The susceptibilities of the aerobic Gram-negative and Gram-positive bacteria recovered from the peritoneal fluid, grouped according to the preoperative length of stay and previous use of any antimicrobial therapy, are summarised in Table 4 . Susceptibility rates ranged from 14% to 100%, Table 3 . Risk of acquiring multidrug-resistant bacteria according to the pre-operative length of hospital stay (< or ‡ 5 days) and use of previous antimicrobial therapy and from 50% to 100%, for Gram-negative and Gram-positive bacteria, respectively. The efficacy of each antimicrobial regimen differed among groups, particularly for Gram-negative bacteria.
D I S C U S S I O N
The incidence of MDR bacteria in secondary peritonitis in this prospective study was 15%.
Patients who had a pre-operative length of hospital stay ‡5 days were at risk for developing an MDR bacterial infection, especially when antibiotics had been used previously. Few studies have evaluated the incidence of MDR bacteria in secondary peritonitis. In a retrospective study of 100 cases of post-operative peritonitis, Montravers et al. [2] found resistance (to at least one antibiotic class to which the bacteria were usually sensitive) in 70% of cases, and multidrug resistance (resistance to at least two antibiotic classes to which the bacteria were usually sensitive) in 37% of cases. The differences in the definition of multidrug resistance and the inclusion of both community-acquired and nosocomial peritonitis in the present study probably explain the discrepancy in the results. If the present study had been restricted to post-operative peritonitis, MDR bacteria would have been observed in 31% (11 ⁄ 35) of cases, similar to the figure reported by Montravers et al. [2] . The therapeutic approach for secondary peritonitis is differentiated typically into three main categories: community-acquired peritonitis, nosocomial post-operative peritonitis, and nosocomial non-post-operative peritonitis (occurring without surgical intervention). Antimicrobial therapy for community-acquired peritonitis is relatively well-codified [7, [17] [18] [19] [20] . Indeed, in this context, the antimicrobial therapy must be targeted at Enterobacteriaceae, particularly Esch. coli, and anaerobes, especially Bacteroides fragilis, while the need for specific therapy against Enterococcus spp. remains controversial [7, [18] [19] [20] . The management of post-operative peritonitis is different, in that the bacteria are frequently resistant to antimicrobial therapy, and it has been shown that inadequate antimicrobial therapy prolongs hospitalisation and is associated with clinical failure and a higher mortality rate [2, 21] . In this context, empirical antimicrobial therapy is based on the local ecology, and frequently requires the use of expanded-spectrum multidrug regimens that in-clude an aminoglycoside or a quinolone, or a carbapenem and vancomycin [7, 22] . Nosocomial non-post-operative peritonitis represents a particular entity that, until recently, was classified as post-operative peritonitis with a high frequency of resistant bacteria [7, 22] . However, a large multicentre study in France has shown that the microbiological characteristics of nosocomial nonpost-operative peritonitis mimic those of community-acquired peritonitis. The empirical antimicrobial therapy usually administered for community-acquired peritonitis remains appropriate, although nosocomial bacteria have also been recovered, without being described precisely [6] . In contrast, the North American Guidelines recommend the use of expanded-spectrum antibiotics for pre-operative patients with prolonged stays, and prolonged (>2 days) pre-operative antimicrobial therapy because of the high risk for acquisition of nosocomial flora [7] . Interestingly, no precise duration of hospitalisation was mentioned in these guidelines, whereas the present study found that a cut-off threshold of 5 days had the best sensitivity and specificity for predicting the acquisition of MDR bacteria.
According to the results obtained in the present study, it is possible to propose a different therapeutic approach, based on an analysis of the riskfactors for acquiring MDR bacteria. Three different groups were identified: (i) patients with a preoperative length of hospital stay of <5 days, with or without previous antimicrobial therapy, who developed an intra-abdominal infection with sensitive bacteria; (ii) patients with a pre-operative length of hospital stay of ‡5 days with previous antimicrobial therapy; and (iii) patients without previous antimicrobial therapy. Following previous use of antimicrobial therapy, the risk of acquiring an MDR Gram-negative organism (Enterobacter spp. producing a cephalosporinase or P. aeruginosa resistant to ticarcillin and ceftazidime) and ⁄ or MRSA, was high (9 ⁄ 24 patients; Table 3 ). In this context, empirical antimicrobial therapy could be a combination of cefepimeamikacin-metronidazole and vancomycin, or a combination of imipenem-amikacin and vancomycin. For patients with no previous antimicrobial therapy, a failure to isolate P. aeruginosa and MRSA allows the use of simpler combinations of cefepime-amikacin-metronidazole, or imipenemamikacin (Table 3) . However, despite a prolonged pre-operative length of stay, with or without previous antibiotic use, a large proportion of the patients were infected with sensitive microorganisms, which emphasises that antimicrobial therapy must be reconsidered as soon as antimicrobial susceptibility results are available.
In conclusion, the main interest of this stratified approach is that it enables the use of targeted empirical antimicrobial therapy based on two simple criteria, and that it limits the use of expanded-spectrum antimicrobial agents in patients with post-operative peritonitis. However, this work has several limitations. First, as it is a single-centre study, the results cannot be extrapolated to another hospital; indeed, knowledge of the local bacterial ecology is an important parameter in the initiation of empirical antimicrobial therapy, and intra-abdominal infection is no exception to this rule [7] . In addition, only the first episode of intra-abdominal infection was taken into account, whereas multiple infections represent a more complex situation in which antibiotics are not always necessary. Nevertheless, knowledge of two simple parameters (preoperative length of hospital stay and previous use of antimicrobial therapy) may provide a more rational basis for selecting the initial therapy of patients with secondary peritonitis.
